Description de l'entreprise
Henry Schein, Inc. (NASDAQ:HSIC) is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites.
Conseil d'administration & Conseil de surveillance
| PDG |
| Stanley M. Bergman |
| Conseil d'administration |
| Ronald N. South, Andrea Albertini, Leigh Benowitz, James P. Breslawski, Trinh Clark, Brad Connett, Michael S. Ettinger, Lorelei McGlynn, Mark E. Mlotek, James Mullins, Kelly Murphy, Christopher Pendergast, Walter Siegel, René Willi |
| Conseil de surveillance |
| Stanley M. Bergman, Mohamad Ali, James P. Breslawski, Deborah Derby, Joseph L. Herring, Kurt P. Kuehn, Philip A. Laskawy, Anne H. Margulies, Mark E. Mlotek, Steven Paladino, Carol Raphael, Scott Serota, Bradley T. Sheares, Reed V. Tuckson |
Données de l'entreprise
| Nom: |
Henry Schein Inc. |
| Adresse: |
135 Duryea Road,Melville, NY 11747, USA |
| Téléphone: |
+1-631-843-5500 |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
www.henryschein.com |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
- |
| IPO date: |
03/11/1995 |
Relations avec les investisseurs
| Nom: |
Graham Stanley |
| Téléphone IR: |
+1-631-843-5500 |
| IR-Fax: |
- |
| E-mail IR: |
investor@henryschein.com
|
